Understanding DNA replication and replication stress as avenues to combat cancer

Valeria Naim

DOI: https://doi.org/10.1038/s42003-024-07250-x

IF: 6.548

2024-11-29

Communications Biology

Abstract:The Collection "DNA Replication and Replication Stress" brings together original research articles, critical reviews, and perspectives from scientists with diverse viewpoints and areas of expertise in DNA replication, genome integrity, and cancer.

biology

What problem does this paper attempt to address?

Global Analysis of Genomic Instability Caused by DNA Replication Stress in Saccharomyces Cerevisiae

Dao-Qiong Zheng,Ke Zhang,Xue-Chang Wu,Piotr A. Mieczkowski,Thomas D. Petes

DOI: https://doi.org/10.1073/pnas.1618129113

2016-01-01

Abstract:Significance One important source of genomic instability associated with tumor cells is DNA replication stress. In the current study, replication stress was induced in yeast by a 10-fold reduction in the level of the replicative DNA polymerase δ. By DNA microarray analysis and high-throughput DNA sequencing, we showed that this stress resulted in very high rates of both large (aneuploidy, mitotic recombination, deletions and duplications, and translocations) and small (point mutations and small insertion/deletions) genetic alterations. Some of these changes resulted in a selective growth advantage of the cells, demonstrating the role of elevated genetic instability in the rapid evolution of cells in challenging growth conditions.
DNA Replication: Mechanisms and Therapeutic Interventions for Diseases

Hao-Yun Song,Rong Shen,Hamid Mahasin,Ya-Nan Guo,De-Gui Wang

DOI: https://doi.org/10.1002/mco2.210

2023-01-01

MedComm

Abstract:Accurate and integral cellular DNA replication is modulated by multiple replication-associated proteins, which is fundamental to preserve genome stability. Furthermore, replication proteins cooperate with multiple DNA damage factors to deal with replication stress through mechanisms beyond their role in replication. Cancer cells with chronic replication stress exhibit aberrant DNA replication and DNA damage response, providing an exploitable therapeutic target in tumors. Numerous evidence has indicated that posttranslational modifications (PTMs) of replication proteins present distinct functions in DNA replication and respond to replication stress. In addition, abundant replication proteins are involved in tumorigenesis and development, which act as diagnostic and prognostic biomarkers in some tumors, implying these proteins act as therapeutic targets in clinical. Replication-target cancer therapy emerges as the times require. In this context, we outline the current investigation of the DNA replication mechanism, and simultaneously enumerate the aberrant expression of replication proteins as hallmark for various diseases, revealing their therapeutic potential for target therapy. Meanwhile, we also discuss current observations that the novel PTM of replication proteins in response to replication stress, which seems to be a promising strategy to eliminate diseases.
Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic

Yuewen Zhang,Lei Wu,Zhao Wang,Jinpeng Wang,Shrabasti Roychoudhury,Bartlomiej Tomasik,Gang Wu,Geng Wang,Xinrui Rao,Rui Zhou

DOI: https://doi.org/10.3389/fonc.2022.838637

IF: 4.7

2022-07-08

Frontiers in Oncology

Abstract:DNA replication is a process fundamental in all living organisms in which deregulation, known as replication stress, often leads to genomic instability, a hallmark of cancer. Most malignant tumors sustain persistent proliferation and tolerate replication stress via increasing reliance to the replication stress response. So whilst replication stress induces genomic instability and tumorigenesis, the replication stress response exhibits a unique cancer-specific vulnerability that can be targeted to induce catastrophic cell proliferation. Radiation therapy, most used in cancer treatment, induces a plethora of DNA lesions that affect DNA integrity and, in-turn, DNA replication. Owing to radiation dose limitations for specific organs and tumor tissue resistance, the therapeutic window is narrow. Thus, a means to eliminate or reduce tumor radioresistance is urgently needed. Current research trends have highlighted the potential of combining replication stress regulators with radiation therapy to capitalize on the high replication stress of tumors. Here, we review the current body of evidence regarding the role of replication stress in tumor progression and discuss potential means of enhancing tumor radiosensitivity by targeting the replication stress response. We offer new insights into the possibility of combining radiation therapy with replication stress drugs for clinical use.

oncology
Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

Yongjian Zhu,Jue Hu,Yiduo Hu,Weiguo Liu

DOI: https://doi.org/10.1016/j.ctrv.2009.06.005

IF: 13.608

2009-01-01

Cancer Treatment Reviews

Abstract:Increased chemo-resistance and radio-resistance of cancer cells is a major obstacle in the treatment and management of malignant cancers. An important mechanism that underlies the development of such therapeutic resistance is that cancer cells recognize DNA lesions induced by DNA-damaging agents and by ionizing radiation, and repair these lesions by activating various DNA repair pathways. Therefore, Use of pharmacological agents that can inhibit certain DNA repair pathways in cancer cells has the potential for enhancing the targeted cytotoxicity of anticancer treatments and reversing the associated therapeutic resistance associated with DNA repair; such agents, offering a promising opportunity to achieve better therapeutic efficacy. Here we review the major DNA repair pathways and discuss recent advances in the development of novel inhibitors of DNA repair pathways; many of these agents are under preclinical/clinical investigation.
DNA replication stress and its impact on chromosome segregation and tumorigenesis

Bi Ning Zhang,Andrés Bueno Venegas,Ian D. Hickson,Wai Kit Chu

DOI: https://doi.org/10.1016/j.semcancer.2018.04.005

IF: 17.012

2019-01-01

Seminars in Cancer Biology

Abstract:Genome instability and cell cycle dysregulation are commonly associated with cancer. DNA replication stress driven by oncogene activation during tumorigenesis is now well established as a source of genome instability. Replication stress generates DNA damage not only during S phase, but also in the subsequent mitosis, where it impacts adversely on chromosome segregation. Some regions of the genome seem particularly sensitive to replication stress-induced instability; most notably, chromosome fragile sites. In this article, we review some of the important issues that have emerged in recent years concerning DNA replication stress and fragile site expression, as well as how chromosome instability is minimized by a family of ring-shaped protein complexes known as SMC proteins. Understanding how replication stress impacts on S phase and mitosis in cancer should provide opportunities for the development of novel and tumour-specific treatments.
The Replication Stress Response on a Narrow Path Between Genomic Instability and Inflammation

Hervé Técher,Philippe Pasero

DOI: https://doi.org/10.3389/fcell.2021.702584

2021-06-25

Abstract:The genome of eukaryotic cells is particularly at risk during the S phase of the cell cycle, when megabases of chromosomal DNA are unwound to generate two identical copies of the genome. This daunting task is executed by thousands of micro-machines called replisomes, acting at fragile structures called replication forks. The correct execution of this replication program depends on the coordinated action of hundreds of different enzymes, from the licensing of replication origins to the termination of DNA replication. This review focuses on the mechanisms that ensure the completion of DNA replication under challenging conditions of endogenous or exogenous origin. It also covers new findings connecting the processing of stalled forks to the release of small DNA fragments into the cytoplasm, activating the cGAS-STING pathway. DNA damage and fork repair comes therefore at a price, which is the activation of an inflammatory response that has both positive and negative impacts on the fate of stressed cells. These new findings have broad implications for the etiology of interferonopathies and for cancer treatment.
Replication stress as a driver of cellular senescence and aging

Lauren M. Herr,Ethan D. Schaffer,Kathleen F. Fuchs,Arindam Datta,Robert M. Brosh

DOI: https://doi.org/10.1038/s42003-024-06263-w

IF: 6.548

2024-05-23

Communications Biology

Abstract:Replication stress refers to slowing or stalling of replication fork progression during DNA synthesis that disrupts faithful copying of the genome. While long considered a nexus for DNA damage, the role of replication stress in aging is under-appreciated. The consequential role of replication stress in promotion of organismal aging phenotypes is evidenced by an extensive list of hereditary accelerated aging disorders marked by molecular defects in factors that promote replication fork progression and operate uniquely in the replication stress response. Additionally, recent studies have revealed cellular pathways and phenotypes elicited by replication stress that align with designated hallmarks of aging. Here we review recent advances demonstrating the role of replication stress as an ultimate driver of cellular senescence and aging. We discuss clinical implications of the intriguing links between cellular senescence and aging including application of senotherapeutic approaches in the context of replication stress.

biology
Impact of R-loops on oncogene-induced replication stress in cancer cells

Jonathan Heuzé,Yea-Lih Lin,Armelle Lengronne,Jérôme Poli,Philippe Pasero

DOI: https://doi.org/10.5802/crbiol.123

2023-09-22

Abstract:Replication stress is an alteration in the progression of replication forks caused by a variety of events of endogenous or exogenous origin. In precancerous lesions, this stress is exacerbated by the deregulation of oncogenic pathways, which notably disrupts the coordination between replication and transcription, and leads to genetic instability and cancer development. It is now well established that transcription can interfere with genome replication in different ways, such as head-on collisions between polymerases, accumulation of positive DNA supercoils or formation of R-loops. These structures form during transcription when nascent RNA reanneals with DNA behind the RNA polymerase, forming a stable DNA:RNA hybrid. In this review, we discuss how these different cotranscriptional processes disrupt the progression of replication forks and how they contribute to genetic instability in cancer cells.
DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells

Shaoran Song,Yaochun Wang,Peijun Liu

DOI: https://doi.org/10.7150/ijbs.67529

2022-01-01

International Journal of Biological Sciences

Abstract:The replication licensing factors strictly regulate the DNA replication origin licensing process to guarantee the stability of the genome. Numerous experimental studies have recently demonstrated that the replication licensing factors as oncogenes are essential for the occurrence and development of cancers. Drug resistance, being one of the main characteristics of cancer stem cells, can cause a high recurrence rate and a low survival rate in patients with different cancers. However, the function of the replication licensing factors in cancer stemness remains unclear. The following article highlights the most recent research on DNA replication origin licensing factors in cancer and their function in anti-cancer drug resistance. Moreover, this article proposes a new perspective that replication licensing factors as chemotherapy shield affect anti-cancer drug resistance by promoting the stemness of cancer cells.
Targeting replication stress in cancer therapy

Alexandre André B A da Costa,Dipanjan Chowdhury,Geoffrey I Shapiro,Alan D D'Andrea,Panagiotis A Konstantinopoulos

DOI: https://doi.org/10.1038/s41573-022-00558-5

Abstract:Replication stress is a major cause of genomic instability and a crucial vulnerability of cancer cells. This vulnerability can be therapeutically targeted by inhibiting kinases that coordinate the DNA damage response with cell cycle control, including ATR, CHK1, WEE1 and MYT1 checkpoint kinases. In addition, inhibiting the DNA damage response releases DNA fragments into the cytoplasm, eliciting an innate immune response. Therefore, several ATR, CHK1, WEE1 and MYT1 inhibitors are undergoing clinical evaluation as monotherapies or in combination with chemotherapy, poly[ADP-ribose]polymerase (PARP) inhibitors, or immune checkpoint inhibitors to capitalize on high replication stress, overcome therapeutic resistance and promote effective antitumour immunity. Here, we review current and emerging approaches for targeting replication stress in cancer, from preclinical and biomarker development to clinical trial evaluation.
"Bridging the DNA divide": Understanding the interplay between replication- gaps and homologous recombination proteins RAD51 and BRCA1/2

Miguel Angel Ramirez-Otero,Vincenzo Costanzo

DOI: https://doi.org/10.1016/j.dnarep.2024.103738

Abstract:A key but often neglected component of genomic instability is the emergence of single-stranded DNA (ssDNA) gaps during DNA replication in the absence of functional homologous recombination (HR) proteins, such as RAD51 and BRCA1/2. Research in prokaryotes has shed light on the dual role of RAD51's bacterial ortholog, RecA, in HR and the protection of replication forks, emphasizing its essential role in preventing the formation of ssDNA gaps, which is vital for cellular viability. This phenomenon was corroborated in eukaryotic cells deficient in HR, where the formation of ssDNA gaps within newly synthesized DNA and their subsequent processing by the MRE11 nuclease were observed. Without functional HR proteins, cells employ alternative ssDNA gap-filling mechanisms to ensure survival, though this compensatory response can compromise genomic stability. A notable example is the involvement of the translesion synthesis (TLS) polymerase POLζ, along with the repair protein POLθ, in the suppression of replicative ssDNA gaps. Persistent ssDNA gaps may result in replication fork collapse, chromosomal anomalies, and cell death, which contribute to cancer progression and resistance to therapy. Elucidating the processes that avert ssDNA gaps and safeguard replication forks is critical for enhancing cancer treatment approaches by exploiting the vulnerabilities of cancer cells in these pathways.
The Prevention and Resolution of DNA Replication–transcription Conflicts in Eukaryotic Cells

Wei Wu,Ian D. Hickson,Ying Liu

DOI: https://doi.org/10.1007/s42764-020-00012-z

2020-01-01

Genome Instability & Disease

Abstract:DNA fulfills two critical roles in a cell by being the template for both DNA replication and RNA transcription. During evolution, eukaryotic cells have adopted multiple strategies to coordinate these two processes to prevent or minimize conflicts that might arise between them. Here, we review the strategies employed by cells to simultaneously accommodate the machineries carrying out DNA replication and transcription, and the mechanisms that are brought into play for resolving conflicts when they do arise. We focus on a group of the so-called ‘difficult-to-replicate’ loci in the human genome, which include chromosome fragile sites, the ribosomal DNA, and telomeres. A failure to resolve conflicts arising between replication and transcription can lead to genome instability, as well as to the initiation of cancer and other age-associated diseases. Understanding the mechanisms required for the resolution of these conflicts could, therefore, open up new therapeutic avenues.
Potential biomarkers of DNA replication stress in cancer

Liqun Ren,Long Chen,Wei Wu,Lorenza Garribba,Huanna Tian,Zihui Liu,Ivan Vogel,Chunhui Li,Ian D. Hickson,Ying Liu

DOI: https://doi.org/10.18632/oncotarget.16940

2017-01-01

Oncotarget

Abstract:Oncogene activation is an established driver of tumorigenesis. An apparently inevitable consequence of oncogene activation is the generation of DNA replication stress (RS), a feature common to most cancer cells. RS, in turn, is a causal factor in the development of chromosome instability (CIN), a near universal feature of solid tumors. It is likely that CIN and RS are mutually reinforcing drivers that not only accelerate tumorigenesis, but also permit cancer cells to adapt to diverse and hostile environments. This article reviews the genetic changes present in cancer cells that influence oncogene-induced RS and CIN, with a particular emphasis on regions of the human genome that show enhanced sensitivity to the destabilizing effects of RS, such as common fragile sites. Because RS exists in a wide range of cancer types, we propose that the proteins involved counteracting this stress are potential biomarkers for indicating the degree of RS in cancer specimens. To test this hypothesis, we conducted a pilot study to validate whether some of proteins that are known from in vitro studies to play an essential role in the RS pathway could be suitable as a biomarker. Our results indicated that this is possible. With this review and pilot study, we aim to accelerate the development of a biomarker for analysis of RS in tumor biopsy specimens, which could ultimately help to stratify patients for different forms of therapy such as the RS inhibitors already undergoing clinical trials.
p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways

Mikael S. Lindström,Jiri Bartek,Apolinar Maya-Mendoza

DOI: https://doi.org/10.1038/s41418-022-00999-w

IF: 12.067

2022-04-20

Cell Death and Differentiation

Abstract:Abstract Despite several decades of intense research focused on understanding function(s) and disease-associated malfunction of p53, there is no sign of any “mid-life crisis” in this rapidly advancing area of biomedicine. Firmly established as the hub of cellular stress responses and tumor suppressor targeted in most malignancies, p53’s many talents continue to surprise us, providing not only fresh insights into cell and organismal biology, but also new avenues to cancer treatment. Among the most fruitful lines of p53 research in recent years have been the discoveries revealing the multifaceted roles of p53-centered pathways in the fundamental processes of DNA replication and ribosome biogenesis (RiBi), along with cellular responses to replication and RiBi stresses, two intertwined areas of cell (patho)physiology that we discuss in this review. Here, we first provide concise introductory notes on the canonical roles of p53, the key interacting proteins, downstream targets and post-translational modifications involved in p53 regulation. We then highlight the emerging involvement of p53 as a key component of the DNA replication Fork Speed Regulatory Network and the mechanistic links of p53 with cellular checkpoint responses to replication stress (RS), the driving force of cancer-associated genomic instability. Next, the tantalizing, yet still rather foggy functional crosstalk between replication and RiBi (nucleolar) stresses is considered, followed by the more defined involvement of p53-mediated monitoring of the multistep process of RiBi, including the latest updates on the RPL5/RPL11/5 S rRNA-MDM2-p53-mediated Impaired Ribosome Biogenesis Checkpoint (IRBC) pathway and its involvement in tumorigenesis. The diverse defects of RiBi and IRBC that predispose and/or contribute to severe human pathologies including developmental syndromes and cancer are then outlined, along with examples of promising small-molecule-based strategies to therapeutically target the RS- and particularly RiBi- stress-tolerance mechanisms to which cancer cells are addicted due to their aberrant DNA replication, repair, and proteo-synthesis demands.

cell biology,biochemistry & molecular biology
Induction of homologous recombination by site-specific replication stress

Marina K Triplett,Matthew J Johnson,Lorraine S Symington

DOI: https://doi.org/10.1016/j.dnarep.2024.103753

2024-08-16

Abstract:DNA replication stress is one of the primary causes of genome instability. In response to replication stress, cells can employ replication restart mechanisms that rely on homologous recombination to resume replication fork progression and preserve genome integrity. In this review, we provide an overview of various methods that have been developed to induce site-specific replication fork stalling or collapse in eukaryotic cells. In particular, we highlight recent studies of mechanisms of replication-associated recombination resulting from site-specific protein-DNA barriers and single-strand breaks, and we discuss the contributions of these findings to our understanding of the consequences of these forms of stress on genome stability.
The TIMELESS effort for timely DNA replication and protection

Jinal A Patel,Hyungjin Kim

DOI: https://doi.org/10.1007/s00018-023-04738-3

2023-03-09

Abstract:Accurate replication of the genome is fundamental to cellular survival and tumor prevention. The DNA replication fork is vulnerable to DNA lesions and damages that impair replisome progression, and improper control over DNA replication stress inevitably causes fork stalling and collapse, a major source of genome instability that fuels tumorigenesis. The integrity of the DNA replication fork is maintained by the fork protection complex (FPC), in which TIMELESS (TIM) constitutes a key scaffold that couples the CMG helicase and replicative polymerase activities, in conjunction with its interaction with other proteins associated with the replication machinery. Loss of TIM or the FPC in general results in impaired fork progression, elevated fork stalling and breakage, and a defect in replication checkpoint activation, thus underscoring its pivotal role in protecting the integrity of both active and stalled replication forks. TIM is upregulated in multiple cancers, which may represent a replication vulnerability of cancer cells that could be exploited for new therapies. Here, we discuss recent advances on our understanding of the multifaceted roles of TIM in DNA replication and stalled fork protection, and how its complex functions are engaged in collaboration with other genome surveillance and maintenance factors.
Replisome Proximal Protein Associations and Dynamic Proteomic Changes at Stalled Replication Forks

Carla-Marie Jurkovic,Jennifer Raisch,Stephanie Tran,Hoang Dong Nguyen,Dominique Lévesque,Michelle S Scott,Eric I Campos,François-Michel Boisvert

DOI: https://doi.org/10.1016/j.mcpro.2024.100767

Abstract:DNA replication is a fundamental cellular process that ensures the transfer of genetic information during cell division. Genome duplication takes place in S phase and requires a dynamic and highly coordinated recruitment of multiple proteins at replication forks. Various genotoxic stressors lead to fork instability and collapse, hence the need for DNA repair pathways. By identifying the multitude of protein interactions implicated in those events, we can better grasp the complex and dynamic molecular mechanisms that facilitate DNA replication and repair. Proximity-dependent biotin identification was used to identify associations with 17 proteins within four core replication components, namely the CDC45/MCM2-7/GINS helicase that unwinds DNA, the DNA polymerases, replication protein A subunits, and histone chaperones needed to disassemble and reassemble chromatin. We further investigated the impact of genotoxic stress on these interactions. This analysis revealed a vast proximity association network with 108 nuclear proteins further modulated in the presence of hydroxyurea; 45 being enriched and 63 depleted. Interestingly, hydroxyurea treatment also caused a redistribution of associations with 11 interactors, meaning that the replisome is dynamically reorganized when stressed. The analysis identified several poorly characterized proteins, thereby uncovering new putative players in the cellular response to DNA replication arrest. It also provides a new comprehensive proteomic framework to understand how cells respond to obstacles during DNA replication.
Dynamics of replication origin over-activation

Haiqing Fu,Christophe E. Redon,Bhushan L. Thakur,Koichi Utani,Robin Sebastian,Sang-Min Jang,Jacob M. Gross,Sara Mosavarpour,Anna B. Marks,Sophie Z. Zhuang,Sarah B. Lazar,Mishal Rao,Shira T. Mencer,Adrian M. Baris,Lorinc S. Pongor,Mirit I. Aladjem

DOI: https://doi.org/10.1038/s41467-021-23835-0

IF: 16.6

2021-06-08

Nature Communications

Abstract:Abstract Safeguards against excess DNA replication are often dysregulated in cancer, and driving cancer cells towards over-replication is a promising therapeutic strategy. We determined DNA synthesis patterns in cancer cells undergoing partial genome re-replication due to perturbed regulatory interactions (re-replicating cells). These cells exhibited slow replication, increased frequency of replication initiation events, and a skewed initiation pattern that preferentially reactivated early-replicating origins. Unlike in cells exposed to replication stress, which activated a novel group of hitherto unutilized (dormant) replication origins, the preferred re-replicating origins arose from the same pool of potential origins as those activated during normal growth. Mechanistically, the skewed initiation pattern reflected a disproportionate distribution of pre-replication complexes on distinct regions of licensed chromatin prior to replication. This distinct pattern suggests that circumventing the strong inhibitory interactions that normally prevent excess DNA synthesis can occur via at least two pathways, each activating a distinct set of replication origins.

multidisciplinary sciences
Exploring DNA Damage and Repair Mechanisms: A Review with Computational Insights

Jiawei Chen,Ravi Potlapalli,Heng Quan,Lingtao Chen,Ying Xie,Seyedamin Pouriyeh,Nazmus Sakib,Lichao Liu,Yixin Xie

DOI: https://doi.org/10.3390/biotech13010003

2024-01-16

BioTech

Abstract:DNA damage is a critical factor contributing to genetic alterations, directly affecting human health, including developing diseases such as cancer and age-related disorders. DNA repair mechanisms play a pivotal role in safeguarding genetic integrity and preventing the onset of these ailments. Over the past decade, substantial progress and pivotal discoveries have been achieved in DNA damage and repair. This comprehensive review paper consolidates research efforts, focusing on DNA repair mechanisms, computational research methods, and associated databases. Our work is a valuable resource for scientists and researchers engaged in computational DNA research, offering the latest insights into DNA-related proteins, diseases, and cutting-edge methodologies. The review addresses key questions, including the major types of DNA damage, common DNA repair mechanisms, the availability of reliable databases for DNA damage and associated diseases, and the predominant computational research methods for enzymes involved in DNA damage and repair.
Mechanisms For Stalled Replication Fork Stabilization: New Targets For Synthetic Lethality Strategies In Cancer Treatments

Hongwei Liao,Fang Ji,Thomas Helleday,Songmin Ying

DOI: https://doi.org/10.15252/embr.201846263

IF: 9.071

2018-01-01

EMBO Reports

Abstract:Timely and faithful duplication of the entire genome depends on completion of replication. Replication forks frequently encounter obstacles that may cause genotoxic fork stalling. Nevertheless, failure to complete replication rarely occurs under normal conditions, which is attributed to an intricate network of proteins that serves to stabilize, repair and restart stalled forks. Indeed, many of the components in this network are encoded by tumour suppressor genes, and their loss of function by mutation or deletion generates genomic instability, a hallmark of cancer. Paradoxically, the same fork-protective network also confers resistance of cancer cells to chemotherapeutic drugs that induce high-level replication stress. Here, we review the mechanisms and major pathways rescuing stalled replication forks, with a focus on fork stabilization preventing fork collapse. A coherent understanding of how cells protect their replication forks will not only provide insight into how cells maintain genome stability, but also unravel potential therapeutic targets for cancers refractory to conventional chemotherapies.

Understanding DNA replication and replication stress as avenues to combat cancer

Global Analysis of Genomic Instability Caused by DNA Replication Stress in Saccharomyces Cerevisiae

DNA Replication: Mechanisms and Therapeutic Interventions for Diseases

Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

DNA replication stress and its impact on chromosome segregation and tumorigenesis

The Replication Stress Response on a Narrow Path Between Genomic Instability and Inflammation

Replication stress as a driver of cellular senescence and aging

Impact of R-loops on oncogene-induced replication stress in cancer cells

DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells

Targeting replication stress in cancer therapy

"Bridging the DNA divide": Understanding the interplay between replication- gaps and homologous recombination proteins RAD51 and BRCA1/2

The Prevention and Resolution of DNA Replication–transcription Conflicts in Eukaryotic Cells

Potential biomarkers of DNA replication stress in cancer

p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways

Induction of homologous recombination by site-specific replication stress

The TIMELESS effort for timely DNA replication and protection

Replisome Proximal Protein Associations and Dynamic Proteomic Changes at Stalled Replication Forks

Dynamics of replication origin over-activation

Exploring DNA Damage and Repair Mechanisms: A Review with Computational Insights

Mechanisms For Stalled Replication Fork Stabilization: New Targets For Synthetic Lethality Strategies In Cancer Treatments